Uptake of human papillomavirus (HPV) vaccine in the United States (US) is far below the
Healthy People 2020 goal of 80% coverage among adolescents. In rural communities, HPV …

Introduction Human papillomavirus (HPV) vaccination protects against HPV-associated
cancers and genital warts. Healthy People 2030 goal for HPV vaccine uptake is 80%, but as …

Background Despite the human papillomavirus (HPV) vaccine being a safe, effective cancer
prevention method, its uptake is suboptimal in the United States (US). Previous research has …

Background Human papillomavirus (HPV) is the most common sexually transmitted infection
in the US with over 80 million infected individuals. High-risk strains are associated with 6 …

Rural communities experience health disparities, including elevated incidence and mortality
of human papillomavirus (HPV)-associated cancers and correspondingly low HPV …

Purpose Compared to US urban populations, rural residents have a higher incidence of
HPV-related cancer and lower HPV vaccine coverage. This study determined what is known …

The objective of this study was to identify factors at the individual, provider, and systems
levels that serve as challenges or opportunities for increasing adolescent vaccination …

OBJECTIVE: Identification of effective strategies is necessary to optimize uptake of the HPV
vaccine. We systematically reviewed the literature for national and international …

Importance Vaccines against human papillomavirus (HPV) are recommended for routine
use in adolescents aged 11 to 12 years in the United States, but uptake remains suboptimal …

Human papillomavirus (HPV) is the most common sexually transmitted infection in the US.
HPV vaccine is a viable source of prevention against high-risk strains that are likely to cause …